PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Washington University School of Medicine in St Louis, St Louis, Missouri.\', \'Cleveland Clinic, Cleveland, Ohio.\', \'Johns Hopkins University School of Medicine, Baltimore, Maryland.\', \'Consortium of MS Centers, Hackensack, New Jersey.\', \'The University of British Columbia, Vancouver, British Columbia, Canada.\', \'MS Society of Canada, Toronto, Ontario, Canada.\', \'National Multiple Sclerosis Society, Chicago, Illinois.\', \'University of Miami School of Medicine, Miami, Florida.\', \'The University of Alabama at Birmingham, Birmingham.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamaneurol.2021.0688
?:hasPublicationType
?:journal
  • JAMA neurology
is ?:pmid of
?:pmid
?:pmid
  • 33739362
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.925
?:rankingScore_hIndex
  • 203
?:title
  • Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all